Related Experiment Videos
High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors
N Inoue1, R K Hirata, D W Russell
1Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington 98195-7720, USA.
Abstract:
The gene targeting techniques used to modify chromosomes in mouse embryonic stem cells have had limited success with many other cell types, especially normal primary cells with restricted growth capacity outside the organism. This is due in large part to the technical problems and/or inefficiency of conventional DNA transfer methods, as well as the low rates of homologous recombination obtained in unselected cell populations. We recently described an alternative approach in which adeno-associated virus (AAV) vectors were used to modify homologous chromosomal sequences, and targeting rates close to 1% were observed at the single copy hypoxanthine phosphoribosyl transferase (HPRT) locus in normal human cells (D. W. Russell and R. K. Hirata, Nat. Genet. 18:325-330, 1998). Here we report experiments in which we used a retroviral shuttle vector system to introduce and characterize target loci in human chromosomes, and demonstrate that AAV vectors can correct several types of mutations with high fidelity, independent of chromosomal position. The gene targeting rates varied depending on the type of mutation being corrected, implicating cellular mismatch recognition functions in the reaction. Since AAV vectors can efficiently deliver DNA to many cell types both in vivo and ex vivo, our results suggest that AAV-mediated gene targeting will have wide applicability, including therapeutic gene correction.
Insights
Adeno-associated virus (AAV) vectors enable efficient gene targeting in human cells, correcting mutations with high fidelity. This breakthrough in gene correction offers broad therapeutic potential for various genetic disorders.
Area of Science:
- Molecular Biology
- Genetics
- Gene Therapy
Background:
- Conventional gene targeting in mouse embryonic stem cells shows limited success in normal primary human cells.
- Inefficiencies in DNA transfer and low homologous recombination rates hinder gene targeting in many cell types.
Purpose of the Study:
- To investigate the use of adeno-associated virus (AAV) vectors for gene targeting in human cells.
- To demonstrate AAV's capability to correct various mutations with high fidelity and chromosomal position independence.
Main Methods:
- Utilized a retroviral shuttle vector system to introduce and characterize target loci in human chromosomes.
- Employed adeno-associated virus (AAV) vectors for gene targeting and mutation correction.
Main Results:
- Achieved gene targeting rates close to 1% at the hypoxanthine phosphoribosyl transferase (HPRT) locus in normal human cells.
- Demonstrated high-fidelity correction of multiple mutation types by AAV vectors, irrespective of chromosomal location.
- Observed varying gene targeting rates dependent on mutation type, suggesting involvement of cellular mismatch recognition.
Conclusions:
- AAV-mediated gene targeting is effective in human cells, overcoming limitations of conventional methods.
- The efficiency and versatility of AAV vectors suggest wide applicability for therapeutic gene correction in vivo and ex vivo.